Assessment of nivolumab exposure and clinical safety of 480 mg every 4 weeks flat-dosing schedule in patients with cancer
Long, G.V., Tykodi, S.S., Schneider, J.G., Garbe, C., Gravis, G., Rashford, M., Agrawal, S., Grigoryeva, E., Bello, A., Roy, A., Rollin, L., Zhao, X.
Published in Annals of oncology (01.11.2018)
Published in Annals of oncology (01.11.2018)
Get full text
Journal Article
Permafrost degradation in the Western Russian Arctic
Vasiliev, Alexander A, Drozdov, Dmitry S, Gravis, Andrey G, Malkova, Galina V, Nyland, Kelsey E, Streletskiy, Dmitry A
Published in Environmental research letters (01.04.2020)
Published in Environmental research letters (01.04.2020)
Get full text
Journal Article
First-line treatment with sunitinib for type 1 and type 2 locally advanced or metastatic papillary renal cell carcinoma: a phase II study (SUPAP) by the French Genitourinary Group (GETUG)
Ravaud, A., Oudard, S., De Fromont, M., Chevreau, C., Gravis, G., Zanetta, S., Theodore, C., Jimenez, M., Sevin, E., Laguerre, B., Rolland, F., Ouali, M., Culine, S., Escudier, B.
Published in Annals of oncology (01.06.2015)
Published in Annals of oncology (01.06.2015)
Get full text
Journal Article
Impact of cabazitaxel on 2-year survival and palliation of tumour-related pain in men with metastatic castration-resistant prostate cancer treated in the TROPIC trial
Bahl, A., Oudard, S., Tombal, B., Özgüroĝlu, M., Hansen, S., Kocak, I., Gravis, G., Devin, J., Shen, L., de Bono, J.S., Sartor, A.O.
Published in Annals of oncology (01.09.2013)
Published in Annals of oncology (01.09.2013)
Get full text
Journal Article
What is the optimal systemic treatment of men with metastatic, hormone-naive prostate cancer? A STOPCAP systematic review and network meta-analysis
Vale, C.L., Fisher, D.J., White, I.R., Carpenter, J.R., Burdett, S., Clarke, N.W., Fizazi, K., Gravis, G., James, N.D., Mason, M.D., Parmar, M.K.B., Rydzewska, L.H., Sweeney, C.J., Spears, M.R., Sydes, M.R., Tierney, J.F.
Published in Annals of oncology (01.05.2018)
Published in Annals of oncology (01.05.2018)
Get full text
Journal Article
Gastrointestinal metastases in renal cell carcinoma: A retrospective multicenter GETUG (Groupe d′Étude des Tumeurs Uro-Génitales) study
Carneiro, F., Vinceneux, A., Larroquette, M., Rony, M., Carril, L., Laguerre, B., Blazevic, I., Bartelemy, P., Teyssonneau, D., Goujon, M., Linassier, C., Thiery-Vuillemin, A., Roubaud, G., Mourey, L., Albiges, L., Gravis, G., Gross-Goupil, M., Cancel, M.
Published in European journal of cancer (1990) (01.03.2024)
Published in European journal of cancer (1990) (01.03.2024)
Get full text
Journal Article
Phase II study of carboplatin and etoposide in patients with anaplastic progressive metastatic castration-resistant prostate cancer (mCRPC) with or without neuroendocrine differentiation: results of the French Genito-Urinary Tumor Group (GETUG) P01 trial
Fléchon, A., Pouessel, D., Ferlay, C., Perol, D., Beuzeboc, P., Gravis, G., Joly, F., Oudard, S., Deplanque, G., Zanetta, S., Fargeot, P., Priou, F., Droz, J.P., Culine, S.
Published in Annals of oncology (01.11.2011)
Published in Annals of oncology (01.11.2011)
Get full text
Journal Article
Urachal carcinoma: a large retrospective multicentric study from the French Genito-Urinary Tumor Group
Guerin, M, Miran, C, Colomba, E, Cabart, M, Herrmann, T, Pericart, S, Maillet, D, Neuzillet, Y, Deleuze, A, Coquan, E, Laramas, M, Thibault, C, Abbar, B, Mesnard, B, Borchiellini, D, Dumont, C, Boughalem, E, Deville, J L, Cancel, M, Saldana, C, Khalil, A, Baciarello, G, Flechon, A, Walz, J, Gravis, G
Published in Frontiers in oncology (19.01.2023)
Published in Frontiers in oncology (19.01.2023)
Get full text
Journal Article
Could thyroid dysfunction influence outcome in sunitinib-treated metastatic renal cell carcinoma?
Sabatier, R., Eymard, J.C., Walz, J., Deville, J.L., Narbonne, H., Boher, J.M., Salem, N., Marcy, M., Brunelle, S., Viens, P., Bladou, F., Gravis, G.
Published in Annals of oncology (01.03.2012)
Published in Annals of oncology (01.03.2012)
Get full text
Journal Article
Combining gemcitabine, cisplatin, and ifosfamide (GIP) is active in patients with relapsed metastatic germ-cell tumors (GCT): a prospective multicenter GETUG phase II trial
Fizazi, K., Gravis, G., Flechon, A., Geoffrois, L., Chevreau, C., Laguerre, B., Delva, R., Eymard, J.C., Rolland, F., Houede, N., Laplanche, A., Burcoveanu, D., Culine, S.
Published in Annals of oncology (01.05.2014)
Published in Annals of oncology (01.05.2014)
Get full text
Journal Article
Does the announcement of cancer at the time of Non Muscle-Invasive Bladder Cancer diagnosis affect quality of life and adherence of patients? Data from the French prospective cohort VICAN
Campagna, J, Touzani, R, Gravis, G, Marino, P, Walz, J, Bendiane, M-K, Bouhnik, A-D, Pignot, G
Published in Progrès en urologie (Paris) (01.01.2022)
Published in Progrès en urologie (Paris) (01.01.2022)
Get more information
Journal Article
Long-term survivors after surgical management of metastatic spinal cord compression
Tabouret, Emeline, Gravis, G., Cauvin, C., Loundou, A., Adetchessi, T., Fuentes, S.
Published in European spine journal (01.01.2015)
Published in European spine journal (01.01.2015)
Get full text
Journal Article
Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial
Choueiri, T.K., Larkin, J., Pal, S., Motzer, R.J., Rini, B.I., Venugopal, B., Alekseev, B., Miyake, H., Gravis, G., Bilen, M.A., Hariharan, S., Chudnovsky, A., Ching, K.A., Mu, X.J., Mariani, M., Robbins, P.B., Huang, B., di Pietro, A., Albiges, L.
Published in ESMO open (01.06.2021)
Published in ESMO open (01.06.2021)
Get full text
Journal Article
Brain metastases response to nivolumab in patients with renal cell carcinoma (RCC): Prospective analysis from the GETUG-AFU 26 (NIVOREN) trial
Flippot, R., Dalban, C., Laguerre, B., Borchiellini, D., Gravis, G., Negrier, S., Chevreau, C.M., Joly, F., Geoffrois, L., Ladoire, S., Mahammedi, H., Tantot, F., Escudier, B., Albiges, L.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
A phase II study of retifanlimab, a humanized anti-PD-1 monoclonal antibody, in patients with solid tumors (POD1UM-203)
Di Giacomo, A.M., Schenker, M., Medioni, J., Mandziuk, S., Majem, M., Gravis, G., Cornfeld, M., Ranganathan, S., Lou, S., Csoszi, T.
Published in ESMO open (01.03.2024)
Published in ESMO open (01.03.2024)
Get full text
Journal Article
Patterns of relapse in poor-prognosis germ-cell tumours in the GETUG 13 trial: Implications for assessment of brain metastases
Loriot, Y., Pagliaro, L., Fléchon, A., Mardiak, J., Geoffrois, L., Kerbrat, P., Chevreau, C., Delva, R., Rolland, F., Theodore, C., Roubaud, G., Gravis, G., Eymard, J.C., Malhaire, J.P., Linassier, C., Habibian, M., Martin, A.L., Journeau, F., Reckova, M., Logothetis, C., Laplanche, A., Le Teuff, G., Culine, S., Fizazi, K.
Published in European journal of cancer (1990) (01.12.2017)
Published in European journal of cancer (1990) (01.12.2017)
Get full text
Journal Article
Q-TWiST analysis of patients with metastatic castrate naive prostate cancer treated by androgen deprivation therapy with or without docetaxel in the randomised phase III GETUG-AFU 15 trial
Marino, P., Sfumato, P., Joly, F., Fizazi, K., Oudard, S., Culine, S., Habibian, M., Boher, J.-M., Gravis, G.
Published in European journal of cancer (1990) (01.10.2017)
Published in European journal of cancer (1990) (01.10.2017)
Get full text
Journal Article
Updated results of GETUG-12, a phase III trial of docetaxel-based chemotherapy in high-risk localized prostate cancer, with a 12-year follow-up
Fizazi, K., Carmel, A., Joly, F., Delva, R., Gravis, G., Rolland, F., Priou, F., Ferrero, J.-M., Houede, N., Mourey, L., Theodore, C., Krakowski, I., Berdah, J.-F., Baciuchka Palmaro, M., Laguerre, B., Flechon, A., Ravaud, A., Brihoum, M., Culine, S., Le Teuff, G.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
RANK/OPG ratio of expression in primary clear-cell renal cell carcinoma is associated with bone metastasis and prognosis in patients treated with anti-VEGFR-TKIs
Beuselinck, B, Jean-Baptiste, J, Couchy, G, Job, S, De Reynies, A, Wolter, P, Théodore, C, Gravis, G, Rousseau, B, Albiges, L, Joniau, S, Verkarre, V, Lerut, E, Patard, J J, Schöffski, P, Méjean, A, Elaidi, R, Oudard, S, Zucman-Rossi, J
Published in British journal of cancer (03.11.2015)
Published in British journal of cancer (03.11.2015)
Get full text
Journal Article